These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 35595970)

  • 1. Long-term evolution and prognostic factors of epilepsy in limbic encephalitis with LGI1 antibodies.
    Guery D; Cousyn L; Navarro V; Picard G; Rogemond V; Bani-Sadr A; Shor N; Joubert B; Muñiz-Castrillo S; Honnorat J; Rheims S
    J Neurol; 2022 Sep; 269(9):5061-5069. PubMed ID: 35595970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
    Huang X; Fan C; Gao L; Li L; Ye J; Shen H
    J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study.
    Muñoz-Lopetegi A; Guasp M; Prades L; Martínez-Hernández E; Rosa-Justícia M; Patricio V; Armangué T; Rami L; Borràs R; Castro-Fornieles J; Compte A; Gaig C; Santamaria J; Dalmau J;
    Lancet Neurol; 2024 Mar; 23(3):256-266. PubMed ID: 38365378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
    Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
    Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of 28 cases of anti
    Feng J; Li J; Xie Y; Lü Y; Bi F; Zhou J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):386-396. PubMed ID: 37164922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seizure underreporting in LGI1 and CASPR2 antibody encephalitis.
    Baumgartner T; Pitsch J; Olaciregui-Dague K; Hoppe C; Racz A; Rüber T; Becker A; von Wrede R; Surges R
    Epilepsia; 2022 Sep; 63(9):e100-e105. PubMed ID: 35735209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of 9 cases with Anti-leucine-rich glioma inactivated 1 protein antibody associated limbic encephalitis].
    Zhang YX; Yang HL; Wu YY; Wang CC; Gao XY; Shi YY; Liu HQ; Huang Y; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2017 May; 97(17):1295-1298. PubMed ID: 28482428
    [No Abstract]   [Full Text] [Related]  

  • 8. When should we test patients with epilepsy for autoimmune antibodies? Results from a French retrospective single center study.
    Kambadja B; Marion H; Cousyn L; Mezouar N; Navarro V; Herlin B; Sophie D
    J Neurol; 2022 Jun; 269(6):3109-3118. PubMed ID: 34816332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis.
    Navarro V; Kas A; Apartis E; Chami L; Rogemond V; Levy P; Psimaras D; Habert MO; Baulac M; Delattre JY; Honnorat J;
    Brain; 2016 Apr; 139(Pt 4):1079-93. PubMed ID: 26945884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seizure characteristics, treatment, and outcome in autoimmune synaptic encephalitis: A long-term study.
    Zhang W; Wang X; Shao N; Ma R; Meng H
    Epilepsy Behav; 2019 May; 94():198-203. PubMed ID: 30974347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ictal electroencephalography (EEG) activity and cerebral blood flow dynamics as potential pathological indicators: a case of anti-leucine-rich glioma-inactivated 1 protein (LGI1) encephalitis].
    Ishibashi H; Neshige S; Aoki S; Ueno H; Iida K; Maruyama H
    Rinsho Shinkeigaku; 2020 Nov; 60(11):778-785. PubMed ID: 33115994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroclinical features of seizures associated with autoimmune encephalitis.
    Steriade C; Moosa ANV; Hantus S; Prayson RA; Alexopoulos A; Rae-Grant A
    Seizure; 2018 Aug; 60():198-204. PubMed ID: 30031297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LGI1 antibody-associated encephalitis without evidence of inflammation in CSF and brain MRI.
    Jia Y; Wang H; Zhang M; Wei M; Huang Z; Ye J; Liu A; Wang Y
    Acta Neurol Belg; 2023 Jun; 123(3):849-856. PubMed ID: 35527332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies.
    Finke C; Prüss H; Heine J; Reuter S; Kopp UA; Wegner F; Then Bergh F; Koch S; Jansen O; Münte T; Deuschl G; Ruprecht K; Stöcker W; Wandinger KP; Paul F; Bartsch T
    JAMA Neurol; 2017 Jan; 74(1):50-59. PubMed ID: 27893017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis.
    Chen C; Wang X; Zhang C; Cui T; Shi WX; Guan HZ; Ren HT; Shao XQ
    Epilepsy Behav; 2017 Dec; 77():90-95. PubMed ID: 29050866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Is Different about Teratoma-Associated Anti-LGI1 Encephalitis? A Long-Term Clinical and Neuroimaging Case Series.
    Li C; Cai HB; Zhao X; Xi XC; Zhou Q; Luo HY; Tang ZP; Kang HC; Kirsch HE
    Eur Neurol; 2022; 85(6):437-445. PubMed ID: 35896086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A feline model of spontaneously occurring autoimmune limbic encephalitis.
    Glantschnigg-Eisl U; Klang A; Kneissl S; Lang B; Waters P; Irani SR; Binks SNM; Pakozdy A
    Vet J; 2023; 296-297():105974. PubMed ID: 36958405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bi-Basal Ganglia Involvement with Signal Evolution in a Case of Anti-LGI1 Encephalitis.
    Gai Q; Ruan S; Dong X; Cong S
    Neurol India; 2022; 70(1):384-386. PubMed ID: 35263922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent hiccup as one of the initial symptoms of leucine-rich glioma-inactivated-1 encephalitis: a case report.
    Hou L; Wan L; Li H; Wang Z; Guan H; Ren H; Wang P
    BMC Neurol; 2022 Jul; 22(1):281. PubMed ID: 35896991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody Properties Associate with Clinical Phenotype in LGI1 Encephalitis.
    Ludewig S; Salzburger L; Goihl A; Rohne J; Leypoldt F; Bittner D; Düzel E; Schraven B; Reinhold D; Korte M; Körtvélyessy P
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.